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Supplemental information 
Materials and Methods   
Reagents 
The following reagents purchased from the indicated manufacturers: rabbit polyclonal 
antibodies against human phosphorylated STAT1, STAT1 and CD38, rabbit monoclonal 
anti-human IRF1 antibody, horseradish peroxidase (HRP)-anti-rabbit IgG and anti-mouse IgG 
from Cell Signaling Technology (Beverly, MA); mouse monoclonal anti-β-actin antibody and 
all trans retinoic acid from Sigma-Aldrich (St. Louis, MO); phycoerythrin-conjugated mouse 
anti-human CD38 antibody and mouse IgG1 from Biolegend (San Diego, CA); 17-AAG from 
Calbiochem EMD Biosciences, Inc. (La Jolla, CA), recombinant human IFN-α and IFN-γ from 
R&D systems, Inc. (bio-techno, USA); and BAY11-7085, entinostat (MS-275) from Santa 
Cruz Biotechnology (Santa Cruz, CA); panobinostat, SR11302 and T-5224 from Cayman 
Chemical Company (Ann Arbor, MI).   
Cells and cell culture  
The use of human samples was approved by the Institutional Review Board at Tokushima 
University, and informed consent was obtained according to the Declaration of Helsinki. 
Peripheral blood mononuclear cells were isolated from fresh peripheral blood as previously 
described1,2. The human MM cell lines RPMI8226, U266-B1 and KMS-11 were obtained from 
the American Type Culture Collection (ATCC, Rockville, MD); OPM-2 was purchased from 
the German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany). The 
human MM cell lines INA-6 and MM.1S were kindly provided by Dr. Renate Burger 
(University of Kiel, Kiel, Germany) and Dr. Steven Rosen (Northwestern University, Chicago, 
IL, USA). Cells were cultured in RPMI1640 medium (Sigma, Aldrich, MO) supplemented with 
10% FBS (Life Technologies, Grand Island, NY), penicillin G at 50 μg/mL and streptomycin at 
50 μg/mL (Sigma).  
Flow cytometry  
Cell preparation and staining in flow cytometry were performed as described previously.1,2 
Briefly, approximately 106 cells were incubated in 100 µL FACS buffer (Japan Blood Products 
Organization, Tokyo, Japan) with phycoerythrin-conjugated monoclonal antibodies on ice for 
45 minutes, and then washed. Samples were analyzed by flow cytometry using a Gallios flow 
cytometer (Beckman Coulter, Miami, FL). Deta were edited with FlowJo software (BD
Biosciences, San Diego, CA). 
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Reverse transcription-polymerase chain reaction (RT-PCR) 
Total RNA was extracted using TRIZOL reagent (Gibco BRL, Rockville, MD). Two µg total 
RNA was reverse-transcribed with Superscript II (Gibco) in a 20 µL reaction solution. One 
tenth of the RT-PCR products were used for subsequent PCR analysis with 23–30 cycles of 
95°C for 30 seconds, 58°C for 30 seconds, and 72°C for 30 seconds. The primers used were 
listed in (Table 1).  
 
Table 1. The list of primers  
 Sense Antisense 
CD38 5'- AAACGGTTTCCCGCAGGTTTG -3' 5'- GTGTCTGAACCTTCTCTGGTTGC-3' 
IRF1 5'- CAAATCCCGGGGCTCATCTG -3' 5'- CTGCTTTCTATCGGCCTGTGTG-3' 
STAT1 5'- TGGTGAAATTGCAAGAGCTGA-3' 5'-GTGTGCGTGCCCAAAATG-3' 
PPIE 5'- TGGACGTACAATTCGTGTCAA -3' 5'- GGCTCTGACCCTTCTTCCTC -3' 
GAPDH 5'- TGTCTTCACCACCATGGAGAAGG -3 5'- GTGGATGCAGGGATGATGTTCTG -3' 
 
 
Short hairpin RNA (shRNA) transfection 
293T cells at a density of 3×105/mL were seeded in 6-wellculture plates in Dulbecco's Modified 
Eagle's medium supplemented with 10% FBS and incubated 24-30 hours. The shRNA encoding 
transfer vector (500 ng/well), dvpr (500 ng/well), and VSV-G (50 ng/well) were mixed in 
TransIT-LT1 transfection reagents containing OPTI-MEM media. After 30 minutes incubation 
at room temperature, 293T cells were transfected with 3 kinds of plasmids for 18 hours at 37℃ 
in 5% CO2. After transfection, 293T cells were re-fed with fresh media. 24 hours later, virus 
particles were harvested. KMS-11 cells were transfected with Mission Lentiviral transduction 
particles, containing IRF1 shRNA (NM_002198 clone TRCN0000218571, TRCN0000229658, 
and TRCN0000229659, Sigma-Aldrich) in the presence of polybrene (8 mg/mL). After 
incubating for 3-5 hours in 6-well culture plates, cells were washed with PBS and resuspended 
in fresh growth media. Transfected cells were selected by incubating with puromycin (1g/mL) 
for 48 hours. Luciferase shRNA was used as a control. Efficacies of gene silencing by shRNA 
were evaluated by RT-PCR.  
 
Western blot analysis  
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Cells were collected and lysed in lysis buffer (Cell Signaling, Beverly, MA) supplemented with 
1 mmoL/L phenylmethylsulfonyl fluoride and protease inhibitor cocktail solution 
(Sigma-Aldrich). The cell lysates were separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) on a 10% polyacrylamide gel, and transferred to polyvinylidene 
difluoride membranes (Millpore, Billerica, MA). Membranes were blocked with 3% non-fat dry 
milk in Tris-buffered saline with 0.01% Tween 20 for 1 hour at room temperature and incubated 
for 16 hours at 4oC with primary antibodies. After washing, secondary horseradish 
peroxidase-conjugated antibody was added, and membranes were then developed, using the 
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Legends to Supplementary Figures 
 
Supplementary Figure 1. (A) Surface expression of CD38 on MM cells. Surface levels of 
CD38 on MM cell lines as indicated were analyzed by flow cytometry. Shaded histograms show 
staining with mouse ΙgG1 isotype control. (B) CD38 upregulation on MM cells by IFN-α and 
ATRA. KMS-11 and MM.1S cells were cultured for 24 hours in the presence or absence of 
IFN-α or ATRA at the indicated concentrations. Surface levels of CD38 on the cells were 
analyzed by flow cytometry. Overlay histograms show CD38 expression on the cells upon the 
indicated treatments. CD38 expression at baseline is indicated as (-). Mouse ΙgG1 was used as 
an isotype control (Iso). (C) Upregulation of CD38 and PD-L1 on MM cells by IFN-α and 
IFN-γ. KMS-11 and MM.1S cells were cultured for 24 hours without stimulation or in the 
presence of 100 U/ml IFN-α or 100 U/ml IFN-γ alone or both in combination. Surface levels of 
CD38 and PD-L1on the cells were analyzed by flow cytometry. 
 
Supplementary Figure 2. Effects of HDAC inhibitors on CD38 expression on MM cells. MM 
cell lines as indicated were cultured for 24 hours in the absence or presence of 100 U/ml 
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IFN-α or 10 nM ATRA alone or both in combination. The pan-HDAC inhibitor panobinostat 
(Pano), the class I HDAC-selective inhibitor MS-275 and the HDAC6-selective inhibitor 
ACY-1215 were further added at 25 nM, 1 µM and 3 µM, respectively, as indicated. CD38 
mRNA expression was analyzed in the MM cells by RT-PCR. GAPDH was used as an internal 
control. 
 
Supplementary Figure 3. (A) Activation of the STAT1-IRF-1 pathway in MM cells by IFN-α. 
After overnight starvation by culture media containing 1% FBS, KMS-11 and MM.1S cells 
were incubated in the presence of IFN-γ (100 U/ml) for the indicated time periods. The cells 
were then harvested, and STAT1, tyrosine-phosphorylated STAT1 (p-STAT1) and IRF1 protein 
levels were examined by Western blot analysis. β-actin was blotted as a loading control. (B) 
Effects of AP-1 inhibition on CD38 upregulation on MM cells by IFN-α and ATRA. KMS-11 
cells were cultured for 24 hours in the presence or absence of 100 U/ml IFN-α or 10 nM ATRA. 
AP-1 inhibitors, SR-11303 or T-5224 were further added at 10 µM as indicated. Surface levels 
of CD38 on the cells were analyzed by flow cytometry. Overlay histograms show CD38 
expression on the cells upon the indicated treatments. CD38 expression at baseline is indicated 
as (-). Mouse ΙgG1 was used as an isotype control (Iso). (C) IRF1 gene knockdown efficacy.  
KMS11 cells were transfected with IRF1 shRNA (IRF1 KD) or control Luciferase shRNA. The 
cells were then cultured for 24 hours in the presence or absence of 100 U/ml IFN-α, 10 nM 
ATRA or 25 nM panobinostat (Pano) alone, or upon treatment with various combination of 
these reagents. IGF1 mRNA expression was analyzed in the MM cells by RT-PCR. PPIE 
(protein coding gene of peptidylprolyl isomerase E) was used as an internal control.   
 
 
